James Dean

James Dean is an experienced clinical operations leader in oncology clinical research, currently serving as Executive Director of Clinical Operations at SELLAS Life Sciences Group, Inc. since May 2023. Prior roles include Director of Clinical Operations at Zentalis Pharmaceuticals, Global Trial Director at Innovent Biologics, and Associate Director at Taiho Oncology. James also has experience as a Clinical Trial Manager at CHDI Foundation, where responsibilities included managing clinical trials for Huntington's Disease. Educational credentials include a Nuclear Medicine Technology Certificate from the University of Medicine and Dentistry of New Jersey and a Bachelor of Science in Biology from New Jersey City University.